~~<i id='F2EB15076B'><strike id='F2EB15076B'><tt id='F2EB15076B'><pre id='F2EB15076B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

fashion

author：comprehensive 2025-09-27 22:46:07 - browse：751

The FDA has taken a big step in encouraging drug companies to include pregnant women in clinical trials, issuing a draft guidance outlining how to do so safely and ethically.

Nearly 4 million women in the U.S. give birth each year, but few drugs have been approved as safe and effective to use during pregnancy. The new guidance aims to help drug companies address those information gaps “through judicious inclusion of pregnant women in clinical trials and careful attention to potential fetal risk.”

Experts say it’s a sign of progress on an issue that’s long plagued pregnant women and their physicians.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Microbiome research is starting to find links to chronic diseases

entertainment

hotspot

focus

hotspot

Wikipedia

leisure time

RobertF.Bukaty/APScientistswhoknowaboutthetypesofpathogens—E.coliandSalmonellaamongthem— thatcanbetr

WSS

Abbott's new stent may help patients with peripheral artery disease

Ukraine and a new approach to mental health in war

Boston hospital trains restaurant workers on naloxone for overdoses

How Vertex's cystic fibrosis drug is changing patients' lives

STAT Virtual Event: Putting AI to the Test

Changes to biosimilar regulatory framework must prioritize patients

knowledge

fashion

entertainment

Alkermes shareholders re

Senate HELP committee spars over health care workforce policies

In Memoriam: Notable people who died in 2023

Obesity drug from Roche shows promise in early study

As demand for Covid shots wanes, Moderna seeks its next success

How Vertex's cystic fibrosis drug is changing patients' lives

Continuity nursing helped my family in our darkest PICU moments

STAT Virtual Event: Putting AI to the Test

BioMarin wins approval for gene therapy to treat hemophilia A

EpiPen alternative approval delay highlights citizen petition issue

hotspot

EpiPen alternative approval delay highlights citizen petition issue

Biotech lab space demand falls sharply

The White House hikes tariffs on plastic syringes made in China

WuXi Biologics execs register to lobby as Congress comes for the company

Changes to biosimilar regulatory framework must prioritize patients

Oak Street deal isn't the answer to health care's woes

focus

hotspot

Wikipedia

leisure time